Ozempic Shows Promise in Dementia Prevention
Tap title to read story
A new study published in JAMA Neurology suggests GLP-1 drugs, like Ozempic and Wegovy, may lower dementia risk in type 2 diabetes patients. Researchers reviewed data from 23 trials involving 160,000 participants and found a statistically significant reduction in dementia or cognitive impairment specifically with GLP-1 receptor agonists. While the exact mechanism is unclear, this finding supports ongoing clinical trials investigating semaglutide's potential as a dementia preventative.
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.













